AB1453 PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS (2024)

AB1453 PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS (1)

  • Subscribe
  • Log In More

    Log in via Institution

    Log in via OpenAthens

    Log in using your username and password

  • Basket
  • Search More

    Advanced search

  • Latest content
  • Current issue
  • Archive
  • Authors
  • About
  • Podcasts

Advanced search

You are here

  • Home
  • Archive
  • Volume 83,Issue Suppl 1
  • AB1453 PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS

Email alerts

Article Text

Article menu

  • Article Text
  • Article info
  • Citation Tools
  • Share
  • Rapid Responses
  • Article metrics
  • Alerts

PDF

Scientific Abstracts

Publication Only

Across diseases

AB1453 PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS

  1. Z. Yang1,
  2. M. MA1,
  3. Y. Liang1,
  4. Y. Wen1,
  5. P. Zhang1,
  6. R. Huang1
  1. 1Guangzhou University of Chinese Medicine, Guangzhou, China

Abstract

Background: Rheumatic diseases, such as rheumatoid arthritis (RA) and ankylosing spondylitis (AS), are marked by disrupted bone metabolism and chronic inflammation. Programmed cell death (PCD), such as ferroptosis, Cuproptosis and pyroptosis, has been reported to participate in various rheumatic diseases[1]. Pyroptosis, a crucial biological event, has been associated with bone metabolism in rheumatic diseases[2], yet the predictive value of pyroptosis in these conditions remains unclear.

Objectives: To investigate the correlation between pyroptotic genes and bone metabolism in rheumatic immune diseases like RA and AS. Utilizing public datasets, RNA-seq, and ELISA assays, this study aims to assess the potential of pyroptotic genes as early indicators of bone damage, incorporating a novel machine learning approach. The findings are intended to support the advancement of precision medicine.

Methods: Prior to the substantive study, we conducted an analysis of different PCD gene sets and bone mineralization/resorption gene sets across 3 public datasets (GSE15258, GSE25101, and GSE73754). In addition, we also used CIBERSORT and single-cell transcriptome sequencing to confirm the cell subpopulation distribution of pyroptotic gene expression. We then utilized RNA-seq to profile the whole-blood transcriptomes of RA and AS patients, as well as healthy volunteers to validate the inference from public data. Concomitantly, ELISA assays were used to evaluate pertinent bone metabolism markers. We further incorporated public datasets and made use of blending machine learning methods to investigate the correlation between pyroptotic gene expression and bone metabolism. The first layer of this blending machine learning model consists of XGBoost, Logistic, and LightGBM, and the second layer is a random forest model. The training set accounted for 85%, the verification set accounted for 15%, and the second layer model selected all samples as the test set.

Results: Our investigation identifies a substantial correlation between pyroptotic gene expression (compared with Apoptosis, Ferroptosis, Autophagy, Necroptosis, Cuproptosis and Parthanatos) and bone metabolism in rheumatic diseases (Figure 1). The distribution of pyroptotic genes was mainly concentrated in macrophage subpopulation. Notably, the pyroptotic genes - TNF, IRF2, CASP8, PYCARD, and NLRC4 successfully predicted the bone resorption score in AS patients (Test set AUC: 0.871, Accuracy: 0.833, Figure 2B), however, fell short in predicting bone mineralization scores (Test set AUC: 0.586, Accuracy: 0.583, Figure 2C). For RA patients, however, these genes were good predictors of both bone resorption (Test set AUC: 0.908, Figure 2D) and bone mineralization scores (Test set AUC: 0.859, Figure 2E). Furthermore, we confirmed a certain correlation between pyroptotic-related gene expression and the ELISA test indicators(including calcium, phosphorus, OPG, RANKL and CTX-I) in our samples.

Conclusion: By integrating RNA-seq profiling, ELISA assays, and blending machine learning analysis, our study emphasizes the complexity of the interplay between pyroptosis and bone metabolism in rheumatic diseases. The pyroptosis-related indicators we discovered allow for early prediction of bone metabolism in rheumatic diseases.

References: [1] Zhao J, Jiang P, Guo S, Schrodi SJ, He D. Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis. FRONT IMMUNOL. 2021 2021/1/20;12:809806.

[2] Zhuang L, Luo X, Wu S, Lin Z, Zhang Y, Zhai Z, et al. Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis. CELL DEATH DISCOV. 2022 2022/9/3;8(1):379.

  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1.

Pyroptosis gene expression demonstrates stronger correlation with bone mineralization and bone resorption indicators when compared to other forms of PCD.

  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2.

Blending Machine Learning Algorithm Unveils the Predictive Value of Pyroptotic Genes

Acknowledgements: NIL.

Disclosure of Interests: None declared.

  • Observational studies/ registry
  • ‘-omics
  • Genetics
  • Artificial Intelligence
  • Bone

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    • Observational studies/ registry
    • ‘-omics
    • Genetics
    • Artificial Intelligence
    • Bone

    Read the full text or download the PDF:

    Subscribe

    Log in via Institution

    Log in via OpenAthens

    Log in using your username and password

    Read the full text or download the PDF:

    Subscribe

    Log in via Institution

    Log in via OpenAthens

    Log in using your username and password

    AB1453 PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS (2024)

    FAQs

    What is the genetic gene for ankylosing spondylitis? ›

    HLA-B27 gene variant

    Research has shown more than 8 out of 10 people with AS carry a particular gene variant known as human leukocyte antigen B27 (HLA-B27).

    Does ankylosing spondylitis have positive rheumatoid factor? ›

    People with spondyloarthritis do not have high titre (concentration) rheumatoid factor antibodies in their blood: they are known as seronegative, whereas people with rheumatoid arthritis can have high or low titre rheumatoid factor antibodies.

    What gene factor is rheumatoid arthritis? ›

    HLA-DR4—This is the gene that is most associated with RA. People who have this gene are more likely to develop RA than those who do not and symptoms may be worse. STAT4—This particular gene regulates and activates the immune system. TRAF1 and C5—These genes play a major role in causing chronic inflammation.

    What genes play the most significant role in the development of rheumatoid arthritis? ›

    The most significant genetic risk factors for rheumatoid arthritis are variations in human leukocyte antigen (HLA) genes , especially the HLA-DRB1 gene.

    Is HLA-B27 inherited from mother or father? ›

    Affected mothers pass on the disease significantly more often to their offspring than do affected fathers. The combination of HLA B60 with HLA B27 increases chances of developing AS by 3–6 times.

    How long can you live with ankylosing spondylitis? ›

    With modern treatments, AS does not normally affect life expectancy significantly, although the condition is associated with an increased risk of other potentially life-threatening problems.

    What labs are elevated with ankylosing spondylitis? ›

    C-reactive protein (CRP): CRP is made in the liver and is one of several proteins that increase in response to inflammation. Testing a sample of blood for CRP levels can provide information about inflammation in the body. CRP is elevated in about 40% of patients with ankylosing spondylitis.

    What are the worst symptoms of ankylosing spondylitis? ›

    A gene may be part of the cause of AS. But an exact cause is unknown. Symptoms of AS include back pain, early morning stiffness, and a stooped posture. AS can cause other symptoms such as appetite loss, weight loss, fatigue, fever, anemia, eye inflammation, and digestive illness.

    What's the difference between rheumatoid arthritis and ankylosing spondylitis? ›

    Affected joints can feel swollen and tender. How is it different? Ankylosing spondylitis usually produces symptoms in the low back, hips, and/or shoulders first. In contrast, rheumatoid arthritis usually first affects smaller joints, such as those in the hands and feet (occasionally the knees are the first affected).

    What is the DNA marker for rheumatoid arthritis? ›

    There is no single rheumatoid arthritis gene. Rather, researchers have identified the location of more than 150 locations that are associated with RA that, coupled with environmental factors, increase the risk of developing the disease. The rheumatoid arthritis genetic markers include STAT4, TRAF1/C5, and PTPN22.

    What genetic disorders mimic rheumatoid arthritis? ›

    Which Conditions Look Like RA?
    • Osteoarthritis.
    • Lupus.
    • Scleroderma.
    • Sjögren's Syndrome.
    • PsA.
    • Lyme.
    • Fibromyalgia.
    • Gout.
    Apr 11, 2024

    What genes are mutated in rheumatoid arthritis? ›

    Genetics and Rheumatoid Arthritis

    The gene link with rheumatoid arthritis is to an immune system gene called HLA-DR4. In rheumatoid arthritis patients of European ancestry, as many as 60–70% carry the HLA-DR4 gene, compared with 30% in the general population.

    Is rheumatoid arthritis considered a disability? ›

    RA isn't always a disability, but it can qualify as one if a person with RA meets specific criteria. The exact criteria depend on the agency or organization you'd like to receive services or benefits from. As a rule, to be considered a disability, RA needs to be severe enough to prevent you from working.

    What else could it be if not rheumatoid arthritis? ›

    Systemic lupus erythematosus (lupus) and scleroderma are two autoimmune diseases that can mimic rheumatoid arthritis. Autoimmune diseases are those in which the body's immune system attacks its own cells and tissues.

    Is lupus inherited from mother or father? ›

    Lupus is not a hereditary condition. However, genetic factors play an important role in the condition, and certain inheritable genes may increase a person's risk of developing lupus. Lupus is a chronic autoimmune condition in which the immune system mistakenly attacks healthy tissue.

    Is HLA-B27 positive rare? ›

    The presence of the HLA-B27 allele varies by geographic region, with more prevalence at northern latitudes. In the United States, the estimated prevalence is six to eight percent. The vast majority of patients with this allele will not develop an HLA-B27 associated syndrome.

    What does it mean if you have the HLA-B27 gene? ›

    A positive test means HLA-B27 is present. It suggests a greater-than-average risk for developing or having certain autoimmune disorders. An autoimmune disorder is a condition that occurs when the immune system mistakenly attacks and destroys healthy body tissue.

    What are three diseases associated with HLA-B27? ›

    Studies indicate that HLA-B27 associated uveitis is a distinct entity characterized by a male predominance and frequent association with seronegative spondyloarthropathies, such as ankylosing spondylitis, reactive arthritis, psoriatic arthritis, and inflammatory bowel disease.

    What is the main cause of ankylosing spondylitis? ›

    Researchers do not know the cause of ankylosing spondylitis. However, studies show that both genes and environment may lead to the development of the disease.

    Top Articles
    Latest Posts
    Recommended Articles
    Article information

    Author: Ray Christiansen

    Last Updated:

    Views: 5850

    Rating: 4.9 / 5 (49 voted)

    Reviews: 80% of readers found this page helpful

    Author information

    Name: Ray Christiansen

    Birthday: 1998-05-04

    Address: Apt. 814 34339 Sauer Islands, Hirtheville, GA 02446-8771

    Phone: +337636892828

    Job: Lead Hospitality Designer

    Hobby: Urban exploration, Tai chi, Lockpicking, Fashion, Gunsmithing, Pottery, Geocaching

    Introduction: My name is Ray Christiansen, I am a fair, good, cute, gentle, vast, glamorous, excited person who loves writing and wants to share my knowledge and understanding with you.